Matthew G Krebs (Matthew Krebs)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO clinical cancer informatics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

University of Manchester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester

United Kingdom

Clinical Senior Lecturer :: Institute of Cancer Sciences

Publications

Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Melinda A Pruis, Matthew G Krebs, Ruth Plummer, Filip Yves Francine De Vos, Eric Angevin, Hans Prenen, Martin D Forster, Glen Clack, Annegret Van der Aa, Marc Tjwa, Ellen Jansen, Timothy Perera, Martijn Paul Lolkema
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer. The oncologist (2023)
Raoul Charles Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi I Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William J Gradishar, Sagar Sardesai, Jason Melear, Joyce O'Shaughnessy, Patrick J Ward, Pavani Chalasani, Tobias Arkenau, Richard D Baird, Rinath M Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew G Krebs
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications 14 (1) (2023)
Matthew G Krebs, Sanjay Popat
RETaliation - tackling rare resistance alterations to osimertinib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Paul O'Regan, Richard Hoskins, Christopher Grave, Julie-Anne Stevenson, Hannah Frost, Donna M Graham, Matthew G Krebs, Andre Freitas, Dónal Landers
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials. JCO clinical cancer informatics 7 (2023)
Raoul Charles Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi I Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William J Gradishar, Sagar Sardesai, Jason Melear, Joyce O'Shaughnessy, Patrick J Ward, Pavani Chalasani, Tobias Arkenau, Richard D Baird, Rinath M Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew G Krebs
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications 14 (1) (2023)
Paul O'Regan, Richard Hoskins, Christopher Grave, Julie-Anne Stevenson, Hannah Frost, Donna M Graham, Matthew G Krebs, Andre Freitas, Dónal Landers
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials. JCO clinical cancer informatics 7 (2023)
Paul O'Regan, Richard Hoskins, Christopher Grave, Julie-Anne Stevenson, Hannah Frost, Donna M Graham, Matthew G Krebs, Andre Freitas, Dónal Landers
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials. JCO clinical cancer informatics 7 (2023)
Robert C Doebele, Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G Krebs, Neal J Meropol, William Bruce Wong, Gracy Crane
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC. Journal of comparative effectiveness research 10 (17) (2021)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Rafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, Salvatore Siena, Alexander E Drilon, Robert C Doebele, Manish R Patel, Byoung Chul Cho, Stephen V Liu, Myung-Ju Ahn, Chao-Hua Chiu, Anna F Farago, Chia-Chi Lin, Christos S Karapetis, Yu-Chung Li, Bann-Mo Day, David Chen, Timothy R Wilson, Fabrice Barlesi
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (11) (2021)
Timothy Anthony Yap, Matthew G Krebs, Sophie Postel-Vinay, Anthony El-Khouiery, Jean-Charles Soria, Juanita Lopez, Alienor Berges, Sy Amy Cheung, Itziar Irurzun-Arana, Andrew Goldwin, Brunella Felicetti, Gemma N Jones, Alan Lau, Paul Frewer, Andrew J Pierce, Glen Clack, Christine Stephens, Simon A Smith, Emma Dean, Simon J Hollingsworth
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Kathryn L Simpson, Ruth Stoney, Kristopher K Frese, Nicole Simms, William Rowe, Simon P Pearce, Sam Humphrey, Laura Booth, Derrick Morgan, Marek Dynowski, Francesca Trapani, Alessia Catozzi, Mitchell Revill, Thomas Helps, Melanie Galvin, Luc Girard, Daisuke Nonaka, Louise Carter, Matthew G Krebs, Natalie Cook, Mathew Carter, Lynsey Priest, Alastair R W Kerr, Adi F Gazdar, Fiona Blackhall, Caroline Dive
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity. Nature cancer 1 (4) (2020)
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Emma Dean, Nigel Smith, Shaun Villa, Joanne Dransfield, Alexandra Clipson, Daniel White, Kamrun Nessa, Saba Ferdous, Matthew Howell, Avinash Gupta, Bedirhan Kilerci, Sumitra Mohan, Kris Frese, Sakshi Gulati, Crispin Miller, Allan Jordan, Helen Eaton, Nicholas Hickson, Ciara O'Brien, Donna Graham, Claire Kelly, Sreeja Aruketty, Robert Metcalf, Jaseela Chiramel, Nadina Tinsley, Alexander J Vickers, Roopa Kurup, Hannah Frost, Julie Stevenson, Siobhan Southam, Dónal Landers, Andrew Wallace, Richard Marais, Andrew M Hughes, Ged Brady, Caroline Dive, Matthew G Krebs
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study. Nature medicine 25 (5) (2019)

Matthew G Krebs.css-eqlu8i{font-size:small;padding-left:4px;} (Matthew Krebs)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew G Krebs (Matthew Krebs)